health π©Ί Ozempic-like drugs linked to hair loss risk
Research found that GLP-1 receptor agonists, like semaglutide and tirzepatide, may cause alopecia as a side effect. This risk was higher for these drug users compared to SGLT-2 inhibitor users in a study from the University of Pennsylvania. The data covered 12,004 GLP-1 users versus 15,221 SGLT-2 inhibitor users between January 2019 and September 2024. While the absolute risk is low, this information can help guide treatment decisions for Type 2 diabetes. Further studies are required to fully understand the underlying mechanisms of this potential issue. π§